Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

December 01, 1994; Volume 46,Issue 6
  • You have access
    The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.
    F Simonin, K Befort, C Gavériaux-Ruff, H Matthes, V Nappey, B Lannes, G Micheletti and B Kieffer
    Molecular Pharmacology December 1994, 46 (6) 1015-1021;
  • You have access
    Purification to homogeneity of the heteromeric DNA-binding form of the aryl hydrocarbon receptor from rat liver.
    E C Henry, G Rucci and T A Gasiewicz
    Molecular Pharmacology December 1994, 46 (6) 1022-1027;
  • You have access
    Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    G Ferrari-Dileo, M Waelbroeck, D C Mash and D D Flynn
    Molecular Pharmacology December 1994, 46 (6) 1028-1035;
  • You have access
    The carboxyl terminus of bovine rhodopsin is not required for G protein activation.
    S Osawa and E R Weiss
    Molecular Pharmacology December 1994, 46 (6) 1036-1040;
  • You have access
    Correlation of activation of Ca2+/calmodulin-dependent protein kinase II with catecholamine secretion and tyrosine hydroxylase activation in cultured bovine adrenal medullary cells.
    M Tsutsui, N Yanagihara, E Miyamoto, A Kuroiwa and F Izumi
    Molecular Pharmacology December 1994, 46 (6) 1041-1047;
  • You have access
    Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor delta subunit.
    M P Blanton, Y M Li, E R Stimson, J E Maggio and J B Cohen
    Molecular Pharmacology December 1994, 46 (6) 1048-1055;
  • You have access
    Chronic exposure to benzodiazepine receptor ligands uncouples the gamma-aminobutyric acid type A receptor in WSS-1 cells.
    G Wong, T Lyon and P Skolnick
    Molecular Pharmacology December 1994, 46 (6) 1056-1062;
  • You have access
    Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.
    H Zhang, D A Cooney, A Sreenath, Q Zhan, R Agbaria, E E Stowe, A J Fornace and D G Johns
    Molecular Pharmacology December 1994, 46 (6) 1063-1069;
  • You have access
    Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
    A Ibrahimi, L Teboul, D Gaillard, E Z Amri, G Ailhaud, P Young, M A Cawthorne and P A Grimaldi
    Molecular Pharmacology December 1994, 46 (6) 1070-1076;
  • You have access
    Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells.
    A Ahlers, C Belka, M Gaestel, N Lamping, C Sott, F Herrmann and M A Brach
    Molecular Pharmacology December 1994, 46 (6) 1077-1083;
  • You have access
    Paradoxical derepression of collagenase gene expression by the antirheumatic gold compound aurothiomalate.
    Y Makino, H Tanaka and I Makino
    Molecular Pharmacology December 1994, 46 (6) 1084-1089;
  • You have access
    Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism.
    S W Grimm, M C Dyroff, R M Philpot and J R Halpert
    Molecular Pharmacology December 1994, 46 (6) 1090-1099;
  • You have access
    Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture.
    Z Abdel-Razzak, L Corcos, A Fautrel, J P Campion and A Guillouzo
    Molecular Pharmacology December 1994, 46 (6) 1100-1110;
  • You have access
    Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
    W Pinto and G Battaglia
    Molecular Pharmacology December 1994, 46 (6) 1111-1119;
  • You have access
    Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors.
    A C Hargreaves, S C Lummis and C W Taylor
    Molecular Pharmacology December 1994, 46 (6) 1120-1128;
  • You have access
    Atypical low density lipoprotein binding site that may mediate lipoprotein-induced signal transduction.
    V A Tkachuk, Y S Kuzmenko, T J Resink, D V Stambolsky and V N Bochkov
    Molecular Pharmacology December 1994, 46 (6) 1129-1137;
  • You have access
    Disruption by lithium of phosphatidylinositol-4,5-bisphosphate supply and inositol-1,4,5-trisphosphate generation in Chinese hamster ovary cells expressing human recombinant m1 muscarinic receptors.
    S Jenkinson, S R Nahorski and R A Challiss
    Molecular Pharmacology December 1994, 46 (6) 1138-1148;
  • You have access
    Gating properties of mutant acetylcholine receptors.
    M L Aylwin and M M White
    Molecular Pharmacology December 1994, 46 (6) 1149-1155;
  • You have access
    Biphasic modulation of the strychnine-sensitive glycine receptor by Zn2+.
    A B Bloomenthal, E Goldwater, D B Pritchett and N L Harrison
    Molecular Pharmacology December 1994, 46 (6) 1156-1159;
  • You have access
    Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864.
    R Farges, E Joseph-Liauzun, D Shire, D Caput, G Le Fur and P Ferrara
    Molecular Pharmacology December 1994, 46 (6) 1160-1167;
  • You have access
    Unusual pharmacology of (+)-tubocurarine with rat neuronal nicotinic acetylcholine receptors containing beta 4 subunits.
    A B Cachelin and G Rust
    Molecular Pharmacology December 1994, 46 (6) 1168-1174;
  • You have access
    4-Aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels.
    N A Castle, S R Fadous, D E Logothetis and G K Wang
    Molecular Pharmacology December 1994, 46 (6) 1175-1181;
  • You have access
    Differential effects of melanocortin peptides on neural melanocortin receptors.
    R A Adan, R D Cone, J P Burbach and W H Gispen
    Molecular Pharmacology December 1994, 46 (6) 1182-1190;
  • You have access
    Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex.
    T Priestley and J A Kemp
    Molecular Pharmacology December 1994, 46 (6) 1191-1196;
  • You have access
    gamma-Aminobutyric acid type A receptor antagonists picrotoxin and bicuculline alter acetylcholine channel kinetics in cultured embryonic rat skeletal muscle.
    Q Y Liu, V Dunlap and J L Barker
    Molecular Pharmacology December 1994, 46 (6) 1197-1203;
  • You have access
    Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells.
    R W Klecker, A G Katki and J M Collins
    Molecular Pharmacology December 1994, 46 (6) 1204-1209;
  • You have access
    Thallium mediates a rapid chloride/hydroxyl ion exchange through myelin lipid bilayers.
    R S Díaz and J Monreal
    Molecular Pharmacology December 1994, 46 (6) 1210-1216;
  • You have access
    Glutathione- and glutathione-S-transferase-dependent oxidative desulfuration of the thione xenobiotic diethyldithiocarbamate methyl ester.
    A Madan, T D Williams and M D Faiman
    Molecular Pharmacology December 1994, 46 (6) 1217-1225;
  • You have access
    Cloning of a novel monoamine oxidase cDNA from trout liver.
    K Chen, H F Wu, J Grimsby and J C Shih
    Molecular Pharmacology December 1994, 46 (6) 1226-1233;
  • You have access
    Doxorubicin, daunorubicin, and mitoxantrone cytotoxicity in yeast.
    C Kule, O Ondrejickova and K Verner
    Molecular Pharmacology December 1994, 46 (6) 1234-1240;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 46, Issue 6
1 Dec 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics